REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 140 filers reported holding REVOLUTION MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $562,236 | +4.7% | 20,312 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $536,846 | +50.1% | 20,069 | +21.5% | 0.00% | +100.0% |
| Q1 2023 | $357,628 | -11.9% | 16,511 | -3.1% | 0.00% | 0.0% |
| Q4 2022 | $405,988 | +32.2% | 17,044 | +9.4% | 0.00% | 0.0% |
| Q3 2022 | $307,000 | +22.3% | 15,586 | +21.2% | 0.00% | 0.0% |
| Q2 2022 | $251,000 | -47.7% | 12,863 | -31.6% | 0.00% | 0.0% |
| Q1 2022 | $480,000 | -18.4% | 18,817 | -19.4% | 0.00% | 0.0% |
| Q4 2021 | $588,000 | -8.4% | 23,352 | +0.1% | 0.00% | -50.0% |
| Q3 2021 | $642,000 | -29.3% | 23,329 | -18.4% | 0.00% | -33.3% |
| Q2 2021 | $908,000 | -7.4% | 28,603 | +33.8% | 0.00% | 0.0% |
| Q1 2021 | $981,000 | +31.9% | 21,379 | +13.8% | 0.00% | 0.0% |
| Q4 2020 | $744,000 | – | 18,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $175,333,000 | 30.61% |
| TRV GP IV, LLC | 1,419,900 | $45,068,000 | 21.46% |
| Ponoi II Management, LLC | 685,011 | $21,742,000 | 17.62% |
| Column Group LLC | 3,347,245 | $106,242,000 | 15.04% |
| Ponoi Management, LLC | 685,011 | $21,742,000 | 12.08% |
| Boxer Capital, LLC | 3,484,264 | $110,591,000 | 3.90% |
| Cormorant Asset Management, LP | 3,338,166 | $105,953,000 | 3.60% |
| BVF INC/IL | 2,485,049 | $78,875,000 | 2.96% |
| Casdin Capital, LLC | 2,305,000 | $73,161,000 | 1.86% |
| Burrage Capital Management LLC | 50,000 | $1,587,000 | 1.59% |